Evogene Ltd.
corporate_fare Company Profile
Evogene Ltd. (NASDAQ:EVGN) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 40 items for EVGN at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Evogene Upsizes ATM to $3.3M and Flags Activist Proxy Fight Risks
- Activist Investors Push for Board Overhaul at Evogene After Building 16.7% Stake
- Evogene Forms Joint Initiative with Tel Aviv University to Boost AI-Driven Drug Discovery
- Evogene Achieves Major AI Milestone with Google Cloud, Advancing Drug Discovery Platform
- Evogene Finalizes Highly Dilutive $2.9M ATM Offering Amidst Delisting and Going Concern Risks
Financial Snapshot
Insider Transactions
EVGN files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.